SH

Shubhrajyoti Halder

Active Director Director DIN 09472030
DIN 09472030 First appointment Jan 2022 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubhrajyoti Halder

Data last updated:

Shubhrajyoti Halder is a Director at Passus Pharma Private Limited (since 2022). The company operates in Business Services.

DIN 09472030
Primary Designation Director
Industry Business Services
First Appointment 18 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Passus Pharma Private Limited U74999WB2022PTC250983
Director18 Jan 20222022Active

Board colleagues of Shubhrajyoti Halder

NameDINCompanyDesignation
Pala Mistri09472031Passus Pharma Private LimitedDirector
Poulami Roy Paul09472032Passus Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Passus Pharma Private Limited
Premium access

Shareholding and investment profile for Shubhrajyoti Halder

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubhrajyoti Halder

Shubhrajyoti Halder currently holds 1 directorship: Passus Pharma Private Limited (Director, since 18 Jan 2022).

Shubhrajyoti Halder was first appointed on 18 Jan 2022 as Director at Passus Pharma Private Limited.

The current boards of Shubhrajyoti Halder's companies include Pala Mistri (Passus Pharma Private Limited), Poulami Roy Paul (Passus Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available